Skip to main content

Jerry Zemaitis, Doug Mann, Joseph Keegan, Gus Davis

Premium
High Throughput Genomics, a gene expression technology company based in Tucson, Ariz., this week announced the appointment of Jerry Zemaitis as vice president of commercial operations.
 
In this newly created position, Zemaitis will be responsible for forming strategic agreements with academic institutions, cultivating new business partnerships, and establishing relationships with domestic and international distributors.
 
Zemaitis was previously founder and principal consultant at Zeta Strategic Consulting, a consulting firm that specializes in business planning and marketing for life sciences and telecommunications companies.
 
Prior to Zeta Strategic Consulting, Zemaitis was vice president of sales at SeraCare Life Sciences and directed business development at both Aclara BioSciences and Caliper Technologies.
 

 
TTP LabTech this week announced that Doug Mann has been appointed field service engineer for its new US facility in Cambridge, Mass. Mann joins US Sales and Support Manager Ben Schenker at the US office (see related story this issue). 
 

 
Alpha Innotech, a San Leandro, Calif.-based bioanalytical systems company, announced this week that Joseph Keegan and Gus Davis have been added to its board of directors.
 
Keegan was previously CEO of Molecular Devices Corporation.
 
Davis previously served as COO of BioSource International. He also served in senior positions with Amersham (acquired by General Electric Healthcare) and Pharmacia Biotechnology.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.